Nabumetone detailed information
Jump to navigation
Jump to search
| File:Nabumetone.svg | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Routes of administration | Oral |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Protein binding | > 99% (active metabolite) |
| Metabolism | Hepatic, to active metabolite 6-methoxy-2-naphthylacetic acid |
| Elimination half-life | 23 hours (active metabolite) |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| DrugBank | |
| Chemical and physical data | |
| Formula | C15H16O2 |
| Molar mass | 228.29 g/mol |
Nabumetone is a non-steroidal anti-inflammatory drug of the arylalkanoic acid family (which includes diclofenac). Marketed under the brand name Relafen, it has been shown to have a slightly lower risk of gastrointestinal side effects than most other non-selective NSAID's.
Categories:
- Articles with short description
- Pages with broken file links
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antipyretics
- Analgesics
- Non-steroidal anti-inflammatory drugs
- Prodrugs
- Drugs